Whole-body diffusion-weighted magnetic resonance imaging: Current evidence in oncology and potential role in colorectal cancer staging.

D.M.J. Lambregts, M. Maas, V.C. Cappendijk, L. Prompers, F.M. Mottaghy, G.L. Beets, R.G.H. Beets-Tan

Research output: Contribution to journalArticleAcademicpeer-review

25 Citations (Scopus)

Abstract

Tumour staging in cancer patients generally entails a multimodality imaging approach. Whole-body (WB) imaging techniques may, however, be more time- and cost-effective than a multimodality approach. 2-Fluorine-18-fluoro-2-deoxy-d-glucose positron emission tomography ((18)FDG-PET), computed tomography (CT) and hybrid positron emission tomography and computed tomography (PET/CT) are the most established WB modalities, although new techniques, amongst which diffusion-weighted magnetic resonance imaging (DWI), are emerging. This review aims to evaluate the current evidence for WB-DWI in oncology, to discuss its potential for the WB staging of (colo)rectal cancer and to relate it to the established WB techniques.
Original languageEnglish
Pages (from-to)2107-2116
Number of pages10
JournalEuropean Journal of Cancer
Volume47
Issue number14
DOIs
Publication statusPublished - Sep 2011

Keywords

  • Diffusion magnetic resonance imaging
  • Whole body imaging
  • Neoplasm staging
  • Colorectal neoplasms
  • POSITRON-EMISSION-TOMOGRAPHY
  • PRIMARY RECTAL-CARCINOMA
  • FOCAL LIVER-LESIONS
  • CELL LUNG-CANCER
  • HIGH-B-VALUE
  • HEPATIC METASTASES
  • PET-CT
  • MALIGNANT-LYMPHOMA
  • RADIATION-THERAPY
  • ADC MEASUREMENTS

Cite this